Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SOXL vs GSK✓SelectedUSD · GSKSOXL vs GSK performance historyLatest closeAs of+0.39%11/18
Stock and ETF performance explorer

SOXL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+8,103.6%
GSK return
+195.6%
Excess return
+7,908.0%
Maximum drawdown
-90.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.4%-1.3%+1.7%+1.9%
7D-25.4%-3.1%-22.3%-22.7%
30D-50.1%-0.9%-49.2%-50.6%
3M-61.8%-4.2%-57.6%-62.2%
6M-67.5%-1.6%-65.9%-71.1%
YTD+17.3%+2.6%+14.7%-5.1%
1Y+43.5%+6.2%+37.3%+10.9%
3Y+116.8%+55.0%+61.8%-19.5%
5Y-25.3%+42.8%-68.1%-71.6%
10Y+1,400.5%+102.1%+1,298.4%+244.8%
All+8,103.6%+195.6%+7,908.0%+713.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling